We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
India pharma industry imports most of the KSMs, intermediates and reasonable quantities of APIs. Majority of these are from one single source – China, which has been affected.
As India Pharma Inc strives to enter new, previously unexplored markets and battles unprecedented challenges, ‘Think Global, Act Local’ approach might be one of the strategies to derive a competitive advantage